🌟 Interactive learning. Real-world application.
Designed for oncologists, urologists, APPs, nurses, pharmacists, and multidisciplinary cancer teams.
👉 ce.ceconcepts.com/COP-002
#Oncology #Urology #AIinHealthcare
15
📋 Case-based learning brings VHL diagnosis & management to life with real-world scenarios.
🔗 ce.ceconcepts.com/BC-142
#CaseBasedLearning #ClinicalEducation
15
🧬 What makes BCMA bispecific antibody + CD38 antibody combinations an exciting area of RRMM research?
Explore their potential immunologic synergy & the science behind emerging treatment approaches.
🎯 ce.ceconcepts.com/COP-004
#BCMA #MultipleMyeloma #CME
18
We are getting ready for all of you in Philadelphia!
Explore MEK inhibitor therapies, surgical strategies, toxicity management & multidisciplinary care for patients with NF1-associated plexiform neurofibromas.
🕕 6 PM ET
💻 Join the livestream: ce.ceconcepts.com/MMS-170
#NF1 #CME
1
46
Optimizing NF1 Tumor Management Across the Lifespan Integrating Pain and Quality-of-Life Assessment into MEK Inhibitor and Surgical Decision-Making teapawt.net/i/broadcasts/2XybqjgXY…
17
🚨 WE GO LIVE IN 15 MINUTES!
Don't miss our NF1 livestream! Explore MEK inhibitors, surgical strategies & individualized care for patients with plexiform neurofibromas.
🕕 Starts at 6 PM ET
💻 Join us: ce.ceconcepts.com/MMS-170
#NF1 #CME
23
⏰ WE GO LIVE IN ONE HOUR!
Join CE Concepts virtually for expert insights on NF1 tumor management, MEK inhibitor therapy, surgery & patient-centered care.
🕕 Starts at 6 PM ET
💻 Register now: ce.ceconcepts.com/MMS-170
#NF1 #CME
20
🔴 TODAY at 6 PM ET!
Join our live NF1 symposium to explore individualized treatment strategies, MEK inhibitors, surgery & quality-of-life considerations for patients with plexiform neurofibromas.
💻 Register: ce.ceconcepts.com/MMS-170
#NF1 #NeuroOncology #CME
27
🚨 TOMORROW! Join our NF1 livestream!
Explore MEK inhibitor therapies, surgical strategies, toxicity management & multidisciplinary care for patients with NF1-associated plexiform neurofibromas.
🕕 6 PM ET
💻 Register: ce.ceconcepts.com/MMS-170
#NF1 #CME
32
WATCH NOW: The FRα Frontier: New Pathways in Platinum-Resistant Ovarian Cancer. Download resources and collect credit: ceconcepts.com/mmv-168-encor… teapawt.net/i/broadcasts/2NgNbVqqQ…
17


